If we need to contact you, we will contact you on this email.
Your name please so that we can credit your work.
Shinya Yamanaka was born on September 4, 1962, in Higashiōsaka, Osaka Prefecture, Japan. Details about his family and early childhood remain largely undisclosed. He attended Tennōji High School, where he graduated with honors. Following high school, Yamanaka enrolled at Kobe University and earned his medical degree in 1987.
After receiving his medical degree, Yamanaka pursued further studies at Osaka City University. Between 1987 and 1989, he worked in orthopedic surgery at the National Osaka Hospital. He completed his Ph.D. at Osaka City University in 1993. That same year, he moved to the United States to join the Gladstone Institutes in San Francisco, California, where he conducted postdoctoral research.
In 1996, Yamanaka returned to Osaka, Japan, to work in a laboratory setting. However, he found the position unfulfilling due to a lack of research opportunities and described the experience as feeling like a "mouse in a trap." Seeking more meaningful work, he accepted a position at the Nara Institute of Science and Technology. There, he began focusing on embryonic stem cells and sought to identify the key characteristics that defined their pluripotency.
Yamanaka served as an associate professor at the Nara Institute from 1999 to 2003, a period that marked the beginning of his groundbreaking research. In 2004, he joined Kyoto University as a professor at the Institute for Frontier Medical Sciences, where he worked until 2010. In 2006, while at Kyoto University and collaborating with his team, Yamanaka successfully generated induced pluripotent stem cells (iPS cells) from adult mouse cells. This major scientific achievement demonstrated that mature cells could be reprogrammed to a pluripotent state by introducing a specific combination of transcription factors.
Yamanaka's discovery that differentiated cells can be reprogrammed into pluripotent stem cells revolutionized the field of regenerative medicine. In 2012, he was awarded the Nobel Prize in Physiology or Medicine alongside John Gurdon for this work. His method, which relies on the introduction of four key transcription factors—often referred to as "Yamanaka factors"—has had a profound impact on stem cell research and therapy.
In addition to his research, Yamanaka has held notable academic and leadership roles. He previously served as a professor of anatomy at the University of California, San Francisco. He also was president of the International Society for Stem Cell Research. As of his tenure at Kyoto University, he directs the Center for iPS Cell Research and Application (CiRA), overseeing ongoing advancements in the field of induced pluripotent stem cells.
Throughout his distinguished career, Yamanaka has received numerous accolades. In 2007, he was named a "Person Who Mattered" by Time magazine and was a Time 100 finalist in 2008. He was awarded the Kyoto Prize in 2010. His work has also earned him the Millennium Technology Prize, worth 1.2 million euros, and the McEwen Award for Innovation, which included a monetary prize of $100,000. These awards highlight his global impact on science and medical innovation.
Outside of his scientific endeavors, Yamanaka practices judo and holds a black belt. He is married to Chika Yamanaka, and together they have two daughters. While his exact net worth is undisclosed, he remains an active public figure and shares updates related to his research and professional activities on social media platforms such as Twitter, Facebook, and Instagram.
Source you received the information from. eg. personal experiences, acquaintances, web-links, etc
Briefly describe the changes you made.